You are here

Clinical Trials: Central Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, December 14, 2016 - 12:00
Condition:   Spinal Cord Injury, Chronic
Interventions:   Drug: XCEL-UMC-BETA;   Drug: Placebo
Sponsors:   Banc de Sang i Teixits;   Hospital de Neurorehabilitació Institut Guttmann;   Recerca Clínica S.L.;   Syntax for Science
Recruiting - verified December 2016
Posted: Tuesday, December 13, 2016 - 12:00
Condition:   Autoimmune Encephalopathy
Intervention:   Drug: Vigabatrin 500 MG
Sponsor:   Seoul National University Hospital
Recruiting - verified December 2016
Posted: Thursday, December 1, 2016 - 12:00
Condition:   Spinal Cord Injuries
Intervention:   Biological: Autologous Mesenchymal Stem Cells
Sponsor:   University of Jordan
Recruiting - verified December 2016
Posted: Thursday, October 20, 2016 - 12:00
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: Stem cell (HPC) implantation
Sponsor:   Cedars-Sinai Medical Center
Not yet recruiting - verified October 2016
Posted: Sunday, October 2, 2016 - 12:00
Condition:   Delayed Encephalopathy After Carbon Monoxide Poisoning
Interventions:   Biological: Human cord blood mononuclear cell;   Other: hyperbaric oxygen
Sponsor:   Liaocheng People's Hospital
Recruiting - verified October 2016
Posted: Monday, September 26, 2016 - 12:00
Intervention:   Other: Two intrathecal MSC injections
Sponsors:   University of Sao Paulo General Hospital;   Pontifícia Universidade Católica do Paraná
Recruiting - verified September 2016
Posted: Tuesday, September 20, 2016 - 12:00
Condition:   Acute Traumatic Spinal Cord Injury
Interventions:   Drug: FAB117-HC;   Other: Control group;   Drug: FAB117-HC
Sponsors:   Ferrer Internacional S.A.;   Histocell S.L.
Not yet recruiting - verified September 2016
Posted: Friday, September 9, 2016 - 12:00
Condition:   Epilepsy
Intervention:   Drug: Omega-3
Sponsor:   Seoul National University Hospital
Recruiting - verified September 2016
Posted: Friday, September 2, 2016 - 12:00
Condition:   Alzheimer's Disease
Interventions:   Biological: CB-AC-02;   Biological: Placebo
Sponsor:   CHABiotech CO., Ltd
Not yet recruiting - verified September 2016
Posted: Thursday, August 25, 2016 - 12:00
Condition:   Huntington Disease
Intervention:   Other: CAPIT-HD beta
Sponsors:   Assistance Publique - Hôpitaux de Paris;   School of Biosciences - Cardiff University;   University Hospital of Wales;   National Reference Center for Huntington's disease Cognitive Neurology Unit;   Institut National de la Santé Et de la Recherche Médicale, France;   Manchester Centre for Genomic Medicine - St. Mary’s Hospital University of Manchester;   George Huntington Institute - Muenster
Recruiting - verified August 2016